An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Obsessive Compulsive Disorder
Interventions
DEVICE

Active DTMS Treatment

H-coil Deep TMS 29 TMS treatments over 6 weeks.

DEVICE

Sham Treatment

29 treatments over 6 weeks.

Trial Locations (12)

10021

Neuropharmacology Services, New York

10029

Mount Sinai Hospital, New York

11777

TMS Hope Center of Long Island, New York

32603

University of Florida College of Medicine, Gainesville

33408

Advanced Mental Health Care Inc. - Juno Beach, Juno Beach

33411

Advanced Mental Health Care Inc. - Royal Palm Beach, Royal Palm Beach

45040

Lindner Center of HOPE, University of Cincinnati College of Medicine, Mason

52621

Tel Hashomer Hospital, Tel Litwinsky

60637

University of Chicago, Chicago

90095

University of California (UCLA), Los Angeles

92093

University of California, San Diego

Unknown

Center for Addiction and Mental Health (CAMH), Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Brainsway

INDUSTRY

NCT02229903 - An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD | Biotech Hunter | Biotech Hunter